Most recent update: Monday, January 21, 2019 - 12:23

Bariatric News - Cookies & privacy policy

You are here

Endobarrier agreement

GI Dynamics paves way for EndoBarrier in Brazil

Exclusive distributor agreement signed following recent regulatory submission
Company expects approval in early 2014

GI Dynamics has entered into an agreement naming CMS Medical as the exclusive distributor of EndoBarrier Therapy in Brazil. The agreement follows the recent submission for registration with the Agência Nacional de Vigilância Sanitária for approval to market EndoBarrier in the country. GI Dynamics is working closely with SciTech Produtos Medicos to help manage the regulatory process.

“We are very pleased to establish this partnership with SciTech and CMS,” said Mark C Twyman, COO of GI Dynamics. “Their knowledge and understanding of the ANVISA registration process will be invaluable as we work toward regulatory approval and commercialization in this market. If all goes well, we expect to launch EndoBarrier Therapy in Brazil in early 2014.”

“Our mission is to work with and bring to market the most advanced healthcare technologies and treatments, said Melchiades da Cunha Neto, co-founder of SciTech. “We look forward to making it broadly available to physicians and patients in Brazil who are struggling to manage these diseases.”

EndoBarrier Therapy is currently available in select countries in Europe, as well as Australia, Chile and most recently, Israel.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.